Protein expression analysis of ALCAM and CEACAM6 in breast cancer metastases reveals significantly increased ALCAM expression in metastases of the skin
Standard
Protein expression analysis of ALCAM and CEACAM6 in breast cancer metastases reveals significantly increased ALCAM expression in metastases of the skin. / Henningsen, Maike; Kilic, Ergin; Koehler, Nadine; Löning, Thomas; Witzel, Isabell; Hagel, Christian; Höller, Sylvia; Kersten, Jan Felix; Müller, Volkmar; Jänicke, Fritz; Milde-Langosch, Karin.
in: J CLIN PATHOL, Jahrgang 64, Nr. 2, 2, 2011, S. 146-152.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Protein expression analysis of ALCAM and CEACAM6 in breast cancer metastases reveals significantly increased ALCAM expression in metastases of the skin
AU - Henningsen, Maike
AU - Kilic, Ergin
AU - Koehler, Nadine
AU - Löning, Thomas
AU - Witzel, Isabell
AU - Hagel, Christian
AU - Höller, Sylvia
AU - Kersten, Jan Felix
AU - Müller, Volkmar
AU - Jänicke, Fritz
AU - Milde-Langosch, Karin
PY - 2011
Y1 - 2011
N2 - For prediction and understanding of underlying mechanisms of organ-specific metastases, various gene and protein expression signatures have been identified in primary breast carcinomas. These expression signatures often include several genes coding for adhesion molecules, such as activated leucocyte cell adhesion molecule (ALCAM/CD166) and carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6), both of which may play an important role in the development of distant metastases because of their adherent properties. Owing to their predominantly membranous localisation, they are also considered to have certain therapeutic potential. Apart from expression data obtained in the primary tumour, data for gene and protein expression patterns in distant breast cancer metastases are rare. Therefore this study focuses on analysing the distribution of ALCAM and CEACAM6 protein expression in breast cancer metastases from different sites.
AB - For prediction and understanding of underlying mechanisms of organ-specific metastases, various gene and protein expression signatures have been identified in primary breast carcinomas. These expression signatures often include several genes coding for adhesion molecules, such as activated leucocyte cell adhesion molecule (ALCAM/CD166) and carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6), both of which may play an important role in the development of distant metastases because of their adherent properties. Owing to their predominantly membranous localisation, they are also considered to have certain therapeutic potential. Apart from expression data obtained in the primary tumour, data for gene and protein expression patterns in distant breast cancer metastases are rare. Therefore this study focuses on analysing the distribution of ALCAM and CEACAM6 protein expression in breast cancer metastases from different sites.
KW - Adult
KW - Humans
KW - Aged
KW - Female
KW - Middle Aged
KW - Aged, 80 and over
KW - Antigens, CD/metabolism
KW - Cell Adhesion Molecules, Neuronal/metabolism
KW - Fetal Proteins/metabolism
KW - Liver Neoplasms/metabolism/secondary
KW - Bone Neoplasms/metabolism/secondary
KW - Brain Neoplasms/metabolism/secondary
KW - Breast Neoplasms/metabolism
KW - Cell Adhesion Molecules/metabolism
KW - GPI-Linked Proteins/metabolism
KW - Lung Neoplasms/metabolism/secondary
KW - Neoplasm Proteins/metabolism
KW - Skin Neoplasms/metabolism/secondary
KW - Adult
KW - Humans
KW - Aged
KW - Female
KW - Middle Aged
KW - Aged, 80 and over
KW - Antigens, CD/metabolism
KW - Cell Adhesion Molecules, Neuronal/metabolism
KW - Fetal Proteins/metabolism
KW - Liver Neoplasms/metabolism/secondary
KW - Bone Neoplasms/metabolism/secondary
KW - Brain Neoplasms/metabolism/secondary
KW - Breast Neoplasms/metabolism
KW - Cell Adhesion Molecules/metabolism
KW - GPI-Linked Proteins/metabolism
KW - Lung Neoplasms/metabolism/secondary
KW - Neoplasm Proteins/metabolism
KW - Skin Neoplasms/metabolism/secondary
U2 - 10.1136/jcp.2010.082602
DO - 10.1136/jcp.2010.082602
M3 - SCORING: Journal article
VL - 64
SP - 146
EP - 152
JO - J CLIN PATHOL
JF - J CLIN PATHOL
SN - 0021-9746
IS - 2
M1 - 2
ER -